Clinical Trial Update: Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS) was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Reconstitution Inflammatory Syndrome
• Progressive Multifocal Leukoencephalopathy

Drugs mentioned

• Corticosteroids (corticosteroids)

Snippet

Sponsor: Biogen | Conditions: Immune Reconstitution Inflammatory Syndrome, Leukoencephalopathy, Progressive Multifocal | Phase 4 | Status: TERMINATED | Results posted: 2014-08-13